Impact of lymph-node metastasis site in patients with thoracic esophageal cancer

Journal of Surgical Oncology

Volumn 101, Issue 1, 2010, Pages 36-42

  Kunisaki, Chikara ^a   Makino, Hirochika ^a   Kimura, Jun ^a   Oshima, Takashi ^a   Fujii, Shoichi ^a   Takagawa, Ryo ^b   Kosaka, Takashi ^b   Ono, Hidetaka A ^b   Akiyama, Hirotoshi ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Lymph node metastasis; Number of metastatic lymph nodes; Site of metastatic lymph nodes; Thoracic esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 74049108588     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21425     Document Type: Article

References (18)

1. Hofstetter W, Correa AM, Bekele N, et al.: Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 2007;84:365-373.
2. Rizk N, Venkatraman E, Park B, et al.: American Joint Committee on Cancer Staging System. The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer Staging System. J Thorac Cardiovasc Surg 2006;132: 1374-1381.
3. Lin CS, Chang SC, Wei YH, et al.: Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg 2009;87:1056-1065. 4. Sobin LH, Wittekind CH, editors. UICC TNM classification of malignant tumor, 6th edition. New York, NY: Wiley; 2002. pp 60-64.
4. Japanese Society for Esophageal Disease. Japanese Classification of Esophageal Cancer, 10th edition. Tokyo: Kanehara Co. Ltd.; 2008.
5. Dhar DK, Hattori S, Tonomoto Y, et al.: Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann Thorac Surg 2007;83:1265-1272.
6. Arima H, Natsugoe S, Uenosono Y, et al.: Area of nodal metastasis and radioisotope uptake in sentinel nodes of upper gastrointestinal cancer. J Surg Res 2006;135:250-254.
7. Lamb PJ, Griffin SM, Burt AD, et al.: Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg 2005;92:60-67.
8. Wilson M, Rosato EL, Chojnacki KA, et al.: Prognostic significance of lymph node metastases and ratio in esophageal cancer. J Surg Res 2008;146:11-15.
9. Mariette C, Piessen G, Briez N, et al.: The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 2008;247:365-371.
10. Greenstein AJ, Litle VR, Swanson SJ, et al.: Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008;206:239-246.
11. Kunisaki C, Akiyama H, Nomura M, et al.: Developing an appropriate staging system for esophageal carcinoma. J Am Coll Surg 2005;201:884-890.
12. Osugi H, Takemura M, Takada N, et al.: Prognostic factors after oesophagectomy and extended lymphadenectomy for squamous oesophageal cancer. Br J Surg 2002;89:909-913.
13. Igaki H, Kato H, Tachimori Y, et al.: Prognostic evaluation of patients with clinical T1 and T2 squamous cell carcinomas of the thoracic esophagus after 3-field lymph node dissection. Surgery 2003;133:368-374.
14. Shimada H, Nabeya Y, Matsubara H, et al.: Prediction of lymph node status in patients with superficial esophageal carcinoma: Analysis of 160 surgically resected cancers. Am J Surg 2006; 191:250-254.
15. Kitagawa Y, Fujii H,MukaiM, et al.: Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 2005;127:123-139.
16. Kato H, Miyazaki T, Nakajima M, et al.: Sentinel lymph nodes with technetium-99m colloidal rhenium sulfide in patients with esophageal carcinoma. Cancer 2003;98:932-939.
17. Shimada H, Okazumi S, Matsubara H, et al.: Surgical outcome after the clearance of abdominal metastatic lymph nodes in 138 patients with thoracic esophageal carcinoma. Am J Surg 2007; 193:448-452.
18. Shimada H, Okazumi S, Matsubara H, et al.: Location and clinical impact of solitary lymph node metastasis in patients with thoracic esophageal carcinoma. Am J Surg 2006;192:306-310.